Clinical Trials Directory

Trials / Completed

CompletedNCT05729269

Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass

Status
Completed
Phase
Study type
Observational
Enrollment
283 (actual)
Sponsor
Chuncheon Sacred Heart Hospital · Academic / Other
Sex
All
Age
24 Years – 82 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to confirm the presence of specific gut microbiota observed in patients with sarcopenia among patients who agreed to analyze gut microbiota through stool among multi-center chronic liver disease cohort patients.

Detailed description

The effect of gut microbiota on liver disease is also well known and many studies are ongoing. A recently published study summarized the differences in the composition of gut microbiota in non-alcoholic fatty liver, steatohepatitis, and cirrhosis, and reported that metabolites from the changed gut microbiota may be a factor influencing non-alcoholic fatty liver disease (NAFLD) progression. These changes in gut microbiota composition have been reported to affect clinical outcomes in patients by causing an increase in endotoxin, a change in bile acid metabolism, and a decrease in short chain fatty acid. In particular, the reduction of short chain fatty acid is known to be associated with the occurrence of sarcopenia. Sarcopenia, which is common in patients with cirrhosis, which is a representative chronic liver disease, is well known as a poor prognostic factor for patients. Therefore, this study aims to analyze the distribution of gut microbiota observed in patients with sarcopenia through the gut microbiota investigated in the chronic liver disease cohort patient group and the characteristics of the distribution of gut microbiota for each disease corresponding to chronic liver disease.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSarcopenia_CTmeasurement of skeletal muscle through abdominal computed tomography

Timeline

Start date
2017-03-22
Primary completion
2019-04-30
Completion
2021-12-31
First posted
2023-02-15
Last updated
2023-02-15

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05729269. Inclusion in this directory is not an endorsement.